PCSK7 genotype modifies effect of a weight-loss diet on 2-year changes of insulin resistance: The pounds lost trial

Diabetes Care

Volumn 38, Issue 3, 2015, Pages 439-444

  Huang, Tao ^a   Huang, Jinyan ^a   Qi, Qibin ^a   Li, Yanping ^a,b   Bray, George A ^c   Rood, Jennifer ^c   Sacks, Frank M ^a   Qi, Lu ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GUANINE; INSULIN; CARBOHYDRATE DIET; IRON; PCSK7 PROTEIN, HUMAN; SUBTILISIN;

ADULT; ARTICLE; CARBOHYDRATE DIET; CAUCASIAN; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MIDDLE AGED; OBESITY; PCSK7 GENE; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION; ALLELE; BODY WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; DIET RESTRICTION; DIET THERAPY; GENETICS; HOMEOSTASIS; LOW CALORY DIET; METABOLISM; MULTICENTER STUDY; PHARMACOLOGY; PROCEDURES;

ALLELES; BODY WEIGHT; DIET, REDUCING; DIETARY CARBOHYDRATES; FASTING; FEMALE; GENOTYPE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; IRON; MALE; MIDDLE AGED; OVERWEIGHT; SUBTILISINS; WEIGHT LOSS;

EID: 84941112168     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0473     Document Type: Article

References (23)

1. Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 2004;27:2422-2428.
2. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004;291:711-717.
3. Ferrannini E. Insulin resistance, iron, and the liver. Lancet 2000;355:2181-2182.
4. Qi L, Meigs J, Manson JE, et al. HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women. Diabetes 2005;54: 3567-3572.
5. Gan W, Guan Y, Wu Q, et al. Association of TMPRSS6 polymorphisms with ferritin, hemoglobin, and type 2 diabetes risk in a Chinese Han population. Am J Clin Nutr 2012;95:626- 632.
6. Oexle K, Ried JS, Hicks AA, et al. Novel association to the proprotein convertase PCSK7 gene locus revealed by analysing soluble transferrin receptor (sTfR) levels. Hum Mol Genet 2011;20:1042-1047.
7. Guillemot J, Canuel M, Essalmani R, Prat A, Seidah NG. Implication of the proprotein convertases in iron homeostasis: Proprotein convertase 7 sheds human transferrin receptor 1 and furin activates hepcidin. Hepatology 2013; 57:2514-2524.
8. Schwienbacher C, Serafin A, Zanon A, Pramstaller PP, Pichler I, Hicks AA. Involvement of proprotein convertase PCSK7 in theregulation of systemic iron homeostasis. Hepatology 2013;58:1860-1861.
9. Croissandeau G, Basak A, Seidah NG, Chŕetien M, Mbikay M. Proprotein convertases are important mediators of the adipocyte differentiation of mouse 3T3-L1 cells. J Cell Sci 2002;115:1203-1211.
10. Smith CE, Arnett DK, Corella D, et al. Perilipin polymorphism interacts with saturated fat and carbohydrates to modulate insulin resistance. NutrMetab Cardiovasc Dis 2012; 22:449-455.
11. Costet P, Cariou B, Lambert G, et al. Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c. J Biol Chem 2006; 281:6211-6218.
12. Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009;360:859-873.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
14. Qi Q, Bray GA, Smith SR, Hu FB, Sacks FM, Qi L. Insulin receptor substrate 1 gene variation modifies insulin resistance response to weightloss diets in a 2-year randomized trial: The Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation 2011;124:563-571.
15. Gabrielsen JS, Gao Y, Simcox JA, et al. Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest 2012;122:3529-3540.
16. Nelsen SM, Christian JL. Site-specific cleavage of BMP4 by furin, PC6, and PC7. J Biol Chem 2009;284:27157-27166.
17. Brand-Miller J, Hayne S, Petocz P, Colagiuri S. Low-glycemic index diets in the management of diabetes: A meta-analysis of randomized controlled trials. Diabetes Care 2003;26:2261-2267.
18. Zhang X, Qi Q, Liang J, Hu FB, Sacks FM, Qi L. Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: The preventing overweight using novel dietary strategies trial. Hypertension 2012;60:1169-1175.
19. Xu M, Qi Q, Liang J, et al. Genetic determinant for amino acid metabolites and changes in body weight and insulin resistance in response to weight-loss diets: The Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation 2013;127: 1283-1289.
20. Foster GD, Wyatt HR, Hill JO, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2003;348:2082-2090.
21. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: A randomized trial. JAMA 2005;293:43-53.
22. Shai I, Schwarzfuchs D, Henkin Y, et al.; Dietary Intervention Randomized Controlled Trial (DIRECT) Group Weight loss with a lowcarbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008;359:229-241.
23. Qi Q, Xu M, Wu H, et al. IRS1 genotype modulates metabolic syndrome reversion in response to 2-year weight-loss diet intervention: The POUNDS LOST trial. Diabetes Care 2013;36: 3442-3447.